Over past decades, a whole range of fluorinated chemicals have been synthesized and used as wetting agents, lubricants, corrosion inhibitors, insecticides, cosmetics, fire retardants, paper coatings, and surfactants ([@b28-ehp0114-000100], [@b29-ehp0114-000100]). The high stability of the carbon--fluorine bond and the inert characteristics of most of these compounds are regarded as attractive properties during the manufacture of plastics, electronics, textiles, or construction materials. For a long time, these fluorinated chemicals were considered metabolically inert and nontoxic ([@b31-ehp0114-000100]). However, environmental monitoring has shown that degradation to persistent molecules does happen on a large scale, as deduced from the worldwide distribution of compounds such as perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorohexanesulfonate, and perfluorooctanesulfonamide ([@b5-ehp0114-000100]; [@b6-ehp0114-000100]; [@b10-ehp0114-000100]; [@b11-ehp0114-000100], [@b12-ehp0114-000100]; [@b23-ehp0114-000100]). [@b23-ehp0114-000100], for instance, describe fluorotelomer alcohols as potential sources of perfluorinated acids in regions as remote as the Arctic. Although the fluorotelomer alcohols are known as volatile chemicals that are capable of long-range atmospheric transport, biologic transformation seems to be the major degradation pathway causing deposition of mentioned perfluorinated acids. In addition, during past years many of the perfluorinated compounds have been found to possess undesirable toxic characteristics. As reviewed by [@b21-ehp0114-000100], perfluoroalkyl acids and their derivatives can cause developmental toxicity. Exposures of rats to PFOA may cause significant lags of weight gain of the offspring and a statistically significant increase in mortality in both male and female pups. PFOS exposure may provoke weight loss, hepatotoxicity, and reduction of serum cholesterol and thyroid hormones. PFOS apparently is also able to affect the neuroendocrine system ([@b1-ehp0114-000100]). Female rats injected with PFOS have a disturbed estrous cyclicity and increased serum corticosterone levels with decreasing serum leptin levels. Increased norepinephrine concentrations were found in the paraventricular nucleus of the hypothalamus. The fact that perfluorinated chemicals may disturb the endocrine system is worrying and deserves further investigation. It is generally known that a well-functioning endocrine system depends on a delicate balance of hormones and hormone receptors that interact to provoke complex cellular signaling. Different environmental pollutants act as hormone mimics, binding to specific hormone receptors or indirectly interfering with hormone signaling. The consequence may be irreversible damage to the reproductive system, especially when living organisms are exposed during the embryonic stages of life ([@b4-ehp0114-000100]; [@b30-ehp0114-000100]). Behavioral changes are another well-known adverse effect of disturbance caused by endocrine-disruptive chemicals ([@b32-ehp0114-000100]). Although disturbance of the thyroid system seems to be provoked by specific perfluorinated chemicals such as PFOS, their potential for estrogen-like properties has not been reported until now. In the present study, we evaluated the capacity of perfluorinated compounds to reinduce cell proliferation of growth-arrested MCF-7 breast cancer cells. Using a combination of the E-screen assay, cell cycle analysis, and gene expression analysis of estrogen-responsive bio-marker genes, we demonstrate the estrogen-like properties of the fluorotelomer alcohols 1H,1H,2H,2H-perfluorooctan-1-ol (6:2 FTOH) and 1H,1H,2H,2H-perfluorodecan-1-ol (8:2 FTOH) *in vitro.*

Materials and Methods
=====================

Chemicals.
----------

PFOS (perfluoro-1-octane sulfonate, tetramethylammonium salt; 98%), 17β-estradiol (E~2~), 4-nonylphenol (4-NP), and PFOA (pentadecafluorooctanoic acid; 96%) were purchased from Sigma-Aldrich (Steinheim, Germany), and perfluorononanoic acid (PFNA; 97%) was provided by Avocado Research Chemicals (Lancashire, UK). We purchased 2,3,7,8-tetrachlorodibenzo-*p*-dioxin (TCDD) from LGC Promochem (Middlesex, UK) and Dulbecco's minimal essential medium (DMEM) and fetal bovine serum (FBS) from Gibco BRL Life Technologies (Paisley, Scotland). 1H,1H,2H,2H-Perfluorooctan-1-ol (6:2 FTOH) and 1H,1H,2H,2H-perfluorodecan-1-ol (8:2 FTOH) were purchased from Interchim (Montlucon, France). We assessed the purity of the fluo-rotelomer alcohol standards by gas chromatography coupled to full-scan mass spectrometry in the electron impact (EI), negative chemical ionization (NCI), and positive chemical ionization (PCI) modes. No impurities could be detected in either EI or PCI mode. In NCI mode, several signals were observed. Retention times and full-scan mass spectra of these signals revealed that they were very closely related to the main signal. They were tentatively elucidated as branched isomers of the FTOHs.

Cell culture.
-------------

MCF-7 human Caucasian breast adenocarcinoma cells (no. 86012803; European Collection of Cell Cultures, Salisbury, UK) were cultured in 25-cm^2^ Nunc cell culture flasks (Nunc, Roskilde, Denmark) in standard growth medium (DMEM; Gibco BRL; supplemented with 2 mM glutamine, 1% nonessential amino acids, 5% heat-inactivated FBS, and phenol red as an indicator of pH). Cells were maintained in a 37°C incubator under a 5% CO~2~ atmosphere over a maximum of 30 passages. Cells were grown to 80--90% confluency before splitting them into one-fifths.

E-screen assay.
---------------

We tested the proliferation-inducing capacity of chemicals using the E-screen assay according to [@b26-ehp0114-000100], with minor modifications to the protocol. In short, cells were seeded in black 96-well microtiter plates with clear, flat bottoms (Nunc) at a density of 2,000 cells/well. Cells attached overnight, after which standard growth medium was replaced with phenol red--free medium containing 5% charcoal/dextran-stripped FBS (CSFBS). A previous wash step with phosphate-buffered saline (PBS) assured removal of all estrogenic compounds. Cells were then incubated for 72 hr to make them estrogen responsive. Exposures to estrogenic compounds or xenoestrogens were started by adding chemicals to the cells from so-called chemical plates. In the latter plates, 2-fold dilution series of the chemicals were prepared, followed by transferring 20--180 μL in the wells of the cell plates. To guarantee minimal interference with cell physiologic responses, the concentration of the solvent (DMSO) did not exceed 0.1%. Plates were covered with gas-permeable sealing tape and incubated at 37°C for 6 days. Proliferation of cells was assessed using the CyQuant assay (Molecular Probes, Invitrogen, Merelbeke, Belgium) ([@b14-ehp0114-000100]).

Cell cycle analysis.
--------------------

We seeded MCF-7 cells in 25-cm^2^ Nunc cell culture flasks in standard growth medium at a density of 300,000 cells/flask. Cells attached overnight, after which the growth medium was replaced by phenol red--free DMEM containing CSFBS. After incubation in estrogen-free medium for 72 hr, cells were exposed to E~2~ or test compounds at concentrations corresponding to the highest observed effect during the E-screen assay. After 24 hr, cells were harvested by trypsinization and washed twice in PBS. Next, cell nuclei were isolated and stained with propidium iodide (PI) for 1 hr as described by [@b42-ehp0114-000100]. We performed flow cytometric analysis of cell cycle distribution and apoptosis with an LSRII flow cytometer with a 488-nm argon-ion laser (Becton Dickinson, San Jose, CA, USA). PI fluorescence was collected at bandpass 575/26 nm(FL2, red fluorescence channel) in the linear mode. For each measurement, data from 10,000 single cell events were collected, whereas cell aggregates and doublets were gated out in the two-parameter histograms of pulse height to pulse width of PI fluorescence. We analyzed cell cycle histograms using ModFit LT 3.0 software (Variety Software House, Topsham, ME, USA).

Gene expression analysis by reverse-transcription polymerase chain reaction (PCR).
----------------------------------------------------------------------------------

MCF-7 cells were seeded and grown in estrogen-free medium in a manner analogous to that described above for flow cytometric analyses. After 48 hr exposure to E~2~ or test compounds, total RNA was extracted from the cell using the RNeasy kit (Qiagen GmbH, Hilden, Germany) according to manufacturer's instructions. RNA quantity and quality were evaluated using a NanoDrop spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). First-strand cDNA was synthesized using the Fermentas first-strand cDNA synthesis kit (MBI Fermentas Life Sciences, St. Leon-Rot, Germany). In brief, 1 μg total RNA was incubated with 0.5 μg oligo(dT)~18~ primer and incubated at 70°C for 5 min to denature RNA. Next, 20 U recombinant ribonuclease inhibitor and 1 mM dNTP mix were added to the RNA in the following reaction buffer: 50 mM Tris-HCl, pH 8.3; 50 mM KCl; 4 mM MgCl~2~; and 10 mM dithiothreitol. cDNA synthesis was started by adding 40 U M-MuLV (Moloney murine leukemia virus) reverse transcriptase at 37°C for 1 hr. Reaction was stopped by inactivation of the reverse transcriptase at 70°C for 10 min. The final volume (20 μL) was adjusted to 100 μL.

We designed highly purified salt-free OliGold primers (Eurogentec, Seraing, Belgium) for the internal control gene hypoxanthine phosphoribosyltransferase 1 (*HPRT1*) and for target genes estrogen receptor-α (*ESR1*), progesterone receptor (*PGR*), PDZ domain containing 1 (*PDZK1)*, and erb-b2 erythroblastic leukemia viral oncogene homolog 2 (*ERBB2*) using Roche Lightcycler software (Roche Diagnostics Belgium, Vilvoorde, Belgium). The sequences of the primers were as follows: for *HPRT1* (GenBank accession no. NM-000194; [@b8-ehp0114-000100]), 5′-TGACACTGGCAAAACAATGCA-3′ and 5′-GGTCCTTTTCACCAGCAAGCT-3′; for *ESR1* (GenBank accession no. NM-000125), 5′-CCATGGAATAGCTAGT-3′ and 5′-CAGTGGCCTAAATCAA-3′; for *PGR* (GenBank accession no. NM-000926). 5′-TGGTCCTTGGAGGTCG-3′ and 5′-GCCTCTCGCCTAGTTG-3′; for *PDZK1* (GenBank accession no. AF012281), 5′-AACCATGACTCGCACA-3′ and 5′-AGCCGTCTGCAATAGC-3′; for *ERBB2* (nuclear receptor ERBB2; GenBank accession no. AF094517), 5′-GACACCTACGGCAGAG-3′ and 5′-GTGGCATCCACTGGAC-3′. The sequences of the primers for trefoil factor 1 (*TFF1*; pS2; GenBank accession no. X00474) as derived from [@b2-ehp0114-000100] were 5′-CATCGACGTCCCTCCAGAAGAG-3′ and 5′-CTCTGGGACTAATCACCGTGCTG-3′.

For the Lightcycler reaction, we prepared a master mix of the following components to the indicated end concentration: 9 μL water, 1 μL forward primer (0.5 μM), 1 μL reverse primer (0.5 μM), and 4 μL Lightcycler Fast Start DNA Master SYBR Green I reagent mixture (Roche). The Lightcycler glass capillaries were filled with 15 μL master mix, and 5 μL cDNA (50 ng reverse-transcribed total RNA) was added as the PCR template. We used the following experimental protocol: denaturation program (95°C for 5 min), amplification program (95°C for 5 sec, 58°C for 5 sec, 72°C for 13 sec, with a single fluorescence measurement at the end of DNA synthesis), melting curve program (55--95°C with a heating rate of 0.1°C/sec and a continuous fluorescence measurement), and finally a cooling step to 40°C. Expression changes of specific target genes were deduced from shifts of the crossing points for the target genes in exposed versus non-exposed cells and normalized by comparison with the internal control gene *HPRT1*. The "crossing point" is the point at which the fluorescence rises appreciably above the background fluorescence. The relative expression ratio of the gene under study normalized by the internal control *HPRT1* gene was calculated using REST software (version 2; [@b27-ehp0114-000100]). We used the pairwise fixed reallocation randomization test included in the REST software to test the significance of the derived results. Each chemical treatment was performed in triplicate, which provided three replicate samples for the reverse-transcriptase (RT)-PCR analyses. To check amplification of the correct PCR products, we performed analysis by 1.5% agarose gel electrophoresis.

Results
=======

Stimulation of MCF-7 cell proliferation.
----------------------------------------

For this study, we adapted the E-screen assay to 96-well microtiter plate format in order to test broad concentration ranges of compounds for their proliferation-inducing capacity in growth-arrested breast cancer cells. In accordance with [@b26-ehp0114-000100], we incubated the MCF-7 cells for 72 hr in estrogen-free growth medium to induce the estrogen responsive.

[Figure 1](#f1-ehp0114-000100){ref-type="fig"} shows the proliferative effect (PE) as a result of exposure to a concentration range of the test compounds. PE (expressed as fold/control) is calculated as the ratio between the cell yield obtained with the test chemical and that with the hormone-free control. [Table 1](#t1-ehp0114-000100){ref-type="table"} presents the relative proliferative effect (RPE), which corresponds to the ratio of the maximal cell yield achieved by the minimum dose of xenobiotic relative to the reference compound (1 nM E~2~) and multiplied by 100. [Table 1](#t1-ehp0114-000100){ref-type="table"} also shows the relative proliferative potency (RPP), which corresponds to the ratio of the dose of E~2~ and that of xenobiotic needed to achieve a maximal PE. As demonstrated in [Figure 1](#f1-ehp0114-000100){ref-type="fig"} and in [Table 1](#t1-ehp0114-000100){ref-type="table"}, 6:2 FTOH and 8:2 FTOH behave like xenoestrogens *in vitro*. These compounds clearly induce cell proliferation at 10 μM, the concentration at which many other xenoestrogens are also active ([@b33-ehp0114-000100]). Neither exposures to PFOS or PFOA within the concentration ranges applied nor the negative control TCDD led to increased cell proliferation.

Effects of perfluorinated compounds on cell cycle distribution.
---------------------------------------------------------------

We performed further evaluation of the fluorinated compounds by flow cytometric analyses of the cell cycle. Although growth-arrested MCF-7 cells are predominantly in the G0/G1-phase of the cell cycle, addition of (xeno-)estrogens makes cells proliferate again, shown by the marked increase in the percentage of cells in the S-phase after 24 hr of exposure.

In [Figure 2](#f2-ehp0114-000100){ref-type="fig"}, the histograms of DNA content show increases in S-phase as the result of exposures to the fluorotelomer alcohols and 4-NP. In [Table 2](#t2-ehp0114-000100){ref-type="table"}, results are expressed as percentages of cells in the different phases of the cell cycle. The increases of cell numbers in the S-phase range from 6% (solvent control) to almost 35% (1 nM E~2~ and 4-NP), approximately 31% (30 μM, 6:2 FTOH), and approximately 29% (10 μM, 8:2 FTOH). PFOS, PFOA, or PFNA, at concentrations ≤ 50 μM, did not affect proliferation. As shown in [Table 3](#t3-ehp0114-000100){ref-type="table"}, fluorotelomer alcohols stimulate MCF-7 cells at concentrations ranging between 10^−6^ and 10^−5^ M. At 10^−7^ M, the stimulatory effect is lost. These results corroborate the findings from the E-screen assay and demonstrate the reinduction of cell proliferation of growth-arrested MCF-7 cells within a much shorter exposure period.

Expression alterations of estrogen-responsive genes.
----------------------------------------------------

Reverse-transcription PCR was performed to analyze the expression of specific estrogen-responsive biomarker genes after 48 hr of exposure. As presented in [Figure 3](#f3-ehp0114-000100){ref-type="fig"}, significantly high up-regulation of *TFF1* mRNA was observed with E~2~ (7×), 4-NP (3.8×), 6:2 FTOH (6.2×), and 8:2 FTOH (2.4×). A small up-regulation was also observed with PFOA (1.4×), and a small but significant down-regulation was observed upon exposure to PFOS (1.7×). Exposure to E~2~ induced very high *PGR* mRNA levels (30×), whereas significant up-regulations were seen with 4-NP (4.5×), 6:2 FTOH (10.4×), and 8:2 FTOH (2.4×). *ESR1* was down-regulated upon exposures to E~2~ (1.33×) or 4-NP (2.1×). With 6:2 FTOH and 8:2 FTOH, however, small but significant up-regulations of *ESR1* were observed (2.2× up with both compounds). PFOS exposure resulted in a significant small down-regulation (3.8×). We studied the expression levels of two additional estrogen-responsive genes in order to further reveal the similarity of the telomeric alcohols to E~2~. An up-regulation of *PDZK1* expression was observed with E~2~ (41×), with 4-NP (13.2×) as well as with both perfluorinated telomeric alcohols (5.4× with 6:2 FTOH and 2.4× with 8:2 FTOH). Significant down-regulation of *ERBB2* was observed with E~2~ (4.5×) and 4-NP (4.4×), whereas less pronounced but nonetheless significant down-regulations were also observed with 6:2 (2.4×) FTOH and 8:2 FTOH (2.4×). A small down-regulation of *ERBB2* was observed with PFOA (1.5×).

Discussion
==========

A range of fluorinated chemicals synthesized during the past few years are promising for various industrial applications ([@b22-ehp0114-000100]). However, because of the persistent nature of these chemicals, monitoring their environmental fate and their ecotoxicologic characteristics is especially warranted ([@b39-ehp0114-000100], [@b38-ehp0114-000100]). Chemicals that are difficult to degrade biologically may bioaccumulate and may affect the health of humans and biota. Disturbance of the endocrine system is one example of the toxic effects that need careful follow-up. Endocrine disruptors may mimic hormones or interfere indirectly with hormonal pathways. Damage caused by these compounds may, in the long term, lead to drastic effects such as decreased reproduction, or perhaps more subtle effects, such as a disturbance to the developmental system resulting in behavioral effects (e.g., learning disorders). Until now, studies that investigated endocrine-disrupting capacities of fluorinated compounds have been difficult to find. In a review describing developmental toxicity of perfluoroalkyl acids, [@b21-ehp0114-000100] highlighted the disturbances of the thyroid gland caused by such compounds (e.g., PFOS causing hypothyroxinemia). Because thyroid hormones are known to regulate brain development, these findings merit further research.

During the present study, the estrogen-like capacities of the fluorinated compounds 6:2 FTOH, 8:2 FTOH, PFOS, PFOA, and PFNA were studied *in vitro*. We used a combination of three different *in vitro* assays to demonstrate these findings. First, we used the E-screen assay, a commonly used high-throughput test to detect estrogen-like compounds in environmental samples. Using this assay, we found that 6:2 FTOH and 8:2 FTOH behave like xenoestrogens *in vitro*. These compounds clearly induce cell proliferation at 10 μM, the concentration at which many other xenoestrogens are also active ([@b33-ehp0114-000100]). To complement and corroborate our E-screen results, we studied cell cycle dynamics using flow cytometry. Cells in estrogen-free growth medium do not enter the S-phase easily ([@b41-ehp0114-000100]). Although \> 80% of the MCF-7 cells were in growth arrest (G0/G1-phase of the cell cycle), the addition of xenoestrogens stimulated cells to synthesize new DNA in preparation of cell division, as revealed by the significant increase of the number of cells in the S-phase of the cell cycle. These increases were clearly observable after 24 hr exposure to the telomeric alcohols. Upon comparison of the E-screen assay with flow cytometric analyses, we found similar effective concentrations of E~2~, 4-NP, and the fluorotelomer alcohols. However, the estrogen-like compounds only induced 2- to 3-fold increases of cell numbers during the E-screen assay, whereas during flow cytometric analyses, we observed up to 5-fold increases of cells in S-phase. Because the exposure periods of E-screen (6 days) and flow cytometric analyses (24 hr) are very different, we also studied cell cycle dynamics after longer exposure periods. After 48 hr, we observed a significant drop of the percentage of cells in S-phase (results not shown). Apparently, cells that are boosted to reenter the cell cycle by a 24-hr xenoestrogen exposure rapidly return to a more modest proliferation rate after 48 hr. One possible explanation is based on the fact that MCF-7 cells express the estrogen receptor as well as the progesterone receptor. Cross-talk exists between nuclear receptors. For instance, progesterone receptor A may act as a repressor of transcriptional activities of different other members of the nuclear receptor family, among them the estrogen receptor ([@b17-ehp0114-000100], [@b18-ehp0114-000100]). A variation in parameters, such as the ratio of progesterone receptor A to progesterone receptor B, may be the consequence of exposures to (xeno-)estrogens, and apparently this altered ratio may dramatically affect estrogen receptor signaling activities. Another important issue to investigate further is the fact that nuclear receptor levels differ in different breast cancer cell lines and even within different clones of a cell line, which may explain why xenoestrogens provoke different cell proliferation responses with different MCF-7 cell lines ([@b3-ehp0114-000100]; [@b41-ehp0114-000100]).

In order to unravel the mode of action of estrogens and xenoestrogens, gene expression analysis of selected estrogen-responsive genes was performed ([@b7-ehp0114-000100]; [@b13-ehp0114-000100]). The expression changes of a small number of estradiol-responsive genes such as *TFF1*, *PGR*, *ESR1*, *PDZK1*, and *ERBB2* were studied using reverse-transcription PCR. *TFF1* is generally accepted as one of the most reliable estrogen-responsive biomarker genes for *in vitro* MCF-7 breast cancer cells ([@b15-ehp0114-000100]; [@b25-ehp0114-000100]; [@b43-ehp0114-000100]). This factor, also known as pS2, belongs to a family of "trefoil peptides" probably involved in the regulation of cell proliferation. *PDZK1* is another frequently reported estrogen-responsive gene ([@b9-ehp0114-000100]; [@b37-ehp0114-000100]). Proteins containing the PDZ domain are involved in organizing cell membrane proteins and are also involved in linking transmembrane proteins to the actin cytoskeleton ([@b36-ehp0114-000100]). The induction of *PDZK1* by E~2~ is suggested to play a crucial role in membrane alterations that happen upon estrogen treatment such as formation of microvilli. *ERBB2* is a transmembrane tyrosine kinase receptor playing a role in mammary oncogenesis. This receptor is up-regulated in MCF-7 cells grown in estradiol-free medium and is down-regulated again upon addition of E~2~ ([@b23-ehp0114-000100]; [@b40-ehp0114-000100]). The estrogen-responsive genes *TFF1*, *PGR*, *PDZK1*, and *ERBB2* were commonly responsive to E~2~ as well as to the xenoestrogen 4-NP and the tested fluorotelomer alcohols. However, although a common up- or down-regulation is observed, the degree of response of the different genes may differ markedly, probably as a consequence of structural differences of the xenoestrogens ([@b35-ehp0114-000100]). These differences may be responsible for and reflect the modes of action. Such differences were also found during the present study. For instance, although 4-NP appears to be a weaker inducer of *TFF1* and *PGR* than 6:2 FTOH, it seems to be a stronger inducer of *PDZK1*. To discriminate between different xenoestrogens with different modes of action, many more estrogen-responsive genes should be studied. Microarray analyses are used to characterize and classify known and newly detected xenoestrogens according to their different modes of action. The MCF-7 cell line may be an attractive model for this kind of study, due to possible cross-talk between the different hormone receptors of this cell line ([@b20-ehp0114-000100]). Although we observed a down-regulation of *ESR1* expression by E~2~ and 4-NP, the fluorotelomer alcohols used in the present study caused a significant, approximately 2-fold up-regulation of this receptor. This finding suggests an alternative mode of action, different from that of the reference compound E~2~. Up-regulation of the estrogen receptor by presumed xenoestrogens is not unusual, as previously demonstrated for endosulfan, toxaphene, and dieldrin ([@b33-ehp0114-000100]).

These results warrant further work toward *in vivo* testing for specific endocrine-disruptive end points. Our results have been generated with an *in vitro* system using a single cell line, confirming the estrogen-like properties at different molecular levels. However, at present, it is not at all clear whether fluorotelomer alcohols are causing endocrine disruption under realistic environmental exposure conditions. Information concerning *in vivo* studies is just becoming available. A one-generation reproductive toxicity study with rats suggests no harmful effect on reproduction ([@b24-ehp0114-000100]). These authors did not observe any test-substance--related effects on estrous cycle parameters or sperm morphology, motility, or epididymal sperm counts in the first parental generation. [@b24-ehp0114-000100] detected no clear estrogen-like properties in this rat *in vivo* study. In another long-term rat exposure study (90 days) using a mixture of fluorotelomer alcohols (at doses ≥ 100 mg/kg/day), [@b19-ehp0114-000100] found a persistent elevation of liver weights and thyroid follicular hypertrophy. One possible explanation for the observed discrepancy between our *in vitro* results and the few *in vivo* data might be related to differences in fluorotelomer metabolism between the breast cancer cell line and the *in vivo* exposure condition. These compounds may be converted in rats to other fluorinated molecules, such as PFOA, and hence, fluorotelomer alcohol exposures result in PFOA-like *in vivo* effects (Berger U, personal communication; Lehmler 2004). Clearly, these possible contradictions between *in vitro* screening assays and *in vivo* data merit further study. At present, it is questionable whether the fluorotelomer alcohols used in the present study might act as endocrine-disrupting xenoestrogens on various organisms that might have different metabolizing capacities. Organisms or individuals with a low fluorotelomer-metabolizing activity might be at risk.

Regarding environmental exposure conditions, few data are available at present. Although fluorotelomer alcohols have been detected in the atmosphere at concentrations up to 135 pg/m^3^ ([@b23-ehp0114-000100]), there are presently no records of these compounds in surface water, sediment, or wildlife.

In conclusion, we characterized fluorotelomer alcohols as xenoestrogens *in vitro*. The structural similarities of these compounds and 4-NP, the reference xenoestrogen, offer a possible explanation why these new compounds may act as ligands for the estrogen receptor ([@b16-ehp0114-000100]). *para*-Alkylphenols have been shown to bind fully to the estrogen receptors in a dose-dependent manner, and the interaction of alkylphenols with the receptor became stronger with an increase in the number of alkyl carbons ([@b34-ehp0114-000100]). In the present study, 6:2 FTOH was characterized as a stronger xenoestrogen than 8:2 FTOH. It is very likely that the chain length of the alkyl group is the responsible factor. The characterization of fluorotelomer alcohols as *in vitro* xenoestrogens demonstrates the need to carefully monitor their environmental distribution and to further investigate the effects of perfluorinated compounds on biota.

This study received support from the Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie through the Generisch basisonderzoek aan de universiteiten project (IWT 020176) titled "Development of Environmental Diagnostics Based on Toxicogenomics and Bio-informatics." This study was further supported by the Fonds voor Wetenschappelijk Onderzoek (G.0355.02N and G.0466.03N) and by the PERFORCE project (European Union, NEST-508967).

![Analysis of estrogenicity of E~2~ (*A*), 4-NP (*B*), 6:2 FTOH (*C*), 8:2 FTOH (*D*), PFOS (*E*), and PFOA (*F* ) by the E-screen assay in MCF-7 cells. 0.1% DMSO was the solvent control. Results are expressed as mean ± SD of three replicates for each data point.](ehp0114-000100f1){#f1-ehp0114-000100}

![Histograms of DNA content showing the effects of perfluorinated compounds on cell cycle distribution. (*A*) 0.1% DMSO (solvent control). Cells were cultured in DMEM plus 5% CSFBS for 72 hr before exposing them to estrogenic compounds (*B*, 1 nM E~2~; *C*, 10 μM 4-NP; *D*, 30 μM 6:2 FTOH; and *E*, 10 μM 8:2 FTOH) and non-estrogenic perfluorinated compounds (*F*, 50 μM PFOS; *G*, 50 μM PFNA) for 24 hr. 4-NP (*C*) was the positive control, and 10 nM TCDD (*H*) was the negative control.](ehp0114-000100f2){#f2-ehp0114-000100}

![Effect of perfluorinated chemicals on mRNA expression of estrogen-responsive genes in MCF-7 cells were treated with 0.1% DMSO, 1 nM E~2~, 10 μM 4-NP, 30 μM 6:2 FTOH, 10 μM 8:2 FTOH, 50 μM PFOS, 50 μM PFNA, 50 μM PFOA, or 10 nM TCDD. After exposure to the test compounds for 48 hr, mRNA levels of *TFF1* (*A*), *PGR* (*B*), *ESR1* (*C*), *PDZK1* (*D*), and *ERBB2* (*E*) were measured by real-time PCR and normalized using *HPRT1* as an internal control. Results are means from three replicate measurements and are expressed as fold relative to 0.1% DMSO; error bars indicate SD.\
\**p* \< 0.05. \*\**p* ≤ 0.001.](ehp0114-000100f3){#f3-ehp0114-000100}

###### 

Estrogenic effect of perfluorinated compounds according to the E-screen assay.

  Compound   Concentration   RPE   RPP
  ---------- --------------- ----- --------
  E~2~       1 nM            100   1
  4-NP       10 μM           100   10^−4^
  6:2 FTOH   10 μM           50    10^−4^
  8:2 FTOH   10 μM           46    10^−4^

###### 

Results of cell cycle analyses of MCF-7 cells exposed to different perfluorinated compounds given as the percentage of cells by phase.

  Treatment          G1/G0-phase    S-phase        G2/M-phase
  ------------------ -------------- -------------- -------------
  0.1% DMSO          90.43 ± 1.01   6.00 ± 1.00    3.57 ± 1.64
  E~2~ (1 nM)        63.14 ± 1.61   34.84 ± 2.48   2.03 ± 0.88
  4-NP (10 μM)       63.71 ± 1.86   34.64 ± 0.47   1.64 ± 1.41
  6:2 FTOH (30 μM)   66.98 ± 4.09   30.83 ± 3.23   2.19 ± 0.87
  8:2 FTOH (10 μM)   68.53 ± 1.48   29.36 ± 1.78   2.11 ± 0.49
  PFOS (50 μM)       85.63 ± 0.94   10.49 ± 0.71   3.87 ± 0.73
  PFNA (50 μM)       85.53 ± 1.64   9.89 ± 1.53    4.57 ± 0.42
  PFOA (50 μM)       83.57 ± 1.04   9.17 ± 0.57    6.83 ± 0.59
  TCDD (10 nM)       87.46 ± 0.30   7.96 ± 0.37    4.58 ± 0.45

Values are mean ± SD of three measurements per treatment. During all measurements, coefficient of variation values of the G0/G1 peak were \< 3.6 (*n* = 3).

###### 

Results of cell cycle analyses of MCF-7 cells exposed to concentrations of fluorotelomer alcohols given as the percentage of cells by phase.

  Treatment           G1/G0-phase    S-phase        G2/M-phase
  ------------------- -------------- -------------- -------------
  0.1% DMSO           90.43 ± 1.01   6.00 ± 1.00    3.57 ± 1.64
  6:2 FTOH (30 μM)    66.98 ± 4.09   30.83 ± 3.23   2.19 ± 0.87
  6:2 FTOH (3 μM)     80.14 ± 3.04   15.63 ± 3.07   4.22 ± 0.34
  6:2 FTOH (0.3 μM)   88.22 ± 0.48   7.89 ± 0.53    3.89 ± 0.38
  8:2 FTOH (10 μM)    68.53 ± 1.48   29.36 ± 1.78   2.11 ± 0.49
  8:2 FTOH (1 μM)     82.70 ± 1.04   12.72 ± 0.84   4.58 ± 0.35
  8:2 FTOH (0.1 μM)   87.04 ± 0.47   8.41 ± 0.04    4.56 ± 0.43

Values are mean ± SD of three measurements per treatment. During all measurements, coefficient of variation values of the G0/G1 peak were \< 3.6 (*n* = 3).
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